After more than a half century as the center of Oklahoma City's culture, sports, politics and entertainment, the Myriad is ...
What Happened? Shares of genetic testing company Myriad Genetics (NASDAQ:MYGN) jumped 10.6% in the morning session after Piper Sandler analysts upgraded the stock's rating from Neutral to Buy. The ...
Morgan Stanley lowered the firm’s price target on Myriad Genetics (MYGN) to $16 from $21 and keeps an Equal Weight rating on the shares after ...
MYRIAD’s new USDC markets will drive more accurate predictions, and redefine the revenue model for media and creator content.
Short sellers have been increasing their bets, with short interest now accounting for 6.1% of the stock's available float.
Before its demolition, the Myriad Center was an oasis for sports, music, arts and memorable events attracting thousands to ...
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...
The protesters, chanting and holding signs, described all manner of grievances against the Trump administration, from ...